Open AccessACCEPTANCE OF ABO-INCOMPATIBLE LIVING DONOR LIVER TRANSPLANTATIONS WITH THE USE OF ANTIGEN-SPECIFIC IMMUNOADSORPTION (GLYCOSORB® ABO), DACLIZUMAB AND MYCOPHENOLATE MOFETIL WITHOUT SPLENECTOMY.
Author(s) -
R. Troisi,
Lucien Noens,
Bart Vandekerckhove,
Roberto Montalti,
S Ricciardi,
Jan Philippé,
Bernard de Hemptinne
Publication year - 2004
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/00007890-200407271-01021
Subject(s) - daclizumab , medicine , immunoadsorption , transplantation , liver transplantation , surgery , gastroenterology , thrombotic microangiopathy , splenectomy , tacrolimus , mycophenolic acid , abo blood group system , urology , immunology , antibody , spleen , disease